Thank you! Your request has been received.
A member of our team will reach out to you shortly,
Oops! Something went wrong while submitting the form.
+
Tailored solutions designed for every life sciences function—from R&D to commercialization.
Knolens gives clinical, HEOR, regulatory, and commercial teams a real-time, unified view of global development. Model strategies, detect risks early, optimize protocols, and align across functions — all from continuously updated internal and public data.
Knolens automates literature reviews across therapeutic areas, extracting structured insights from global sources. Identify comparators, endpoints, and payer concerns fast. Generate PRISMA-compliant outputs to support R&D, regulatory filings, and market access — all from one unified platform.
Knolens enables real-time tracking of global regulatory changes, HTA feedback, and competitor filings. Adapt trial designs, validate endpoints, and refine access strategies — all within a unified, predictive framework that drives compliant, market-aligned development.
Drive portfolio strategy with Knolens. Model clinical, regulatory, and market risks, simulate asset value, and align global teams on launch and investment priorities — maximizing ROI across the pipeline.
With Knolens, pharma teams can collaborate in real time using shared, traceable data. Align strategies across functions, accelerate pricing and access planning, and drive smarter, agile decisions across the product lifecycle.
Reduce Study Design Iterations and Accelerate Time-to-First-Patient
Proactively Anticipate and Address Payer and HTA Objections
Optimize Evidence Generation Strategies for Market-Specific Value Demonstrations
Enhance Cross-Market Pricing, Reimbursement, and Access Strategies
Improve Coordination and Alignment Between Global and Local Teams
Strengthen Value-Based Contracting with Robust, Defensible Evidence
Accelerate asset validation with real-time data analysis by identifying optimal targets and mechanisms of action through clinical, competitive, and real-world insights, while proactively assessing regulatory and payer landscapes to anticipate development challenges.
Design smarter trials with real-world data and competitor insights. Model endpoints, protocols, and populations. Align early with regulatory trends and feasibility signals to reduce risk and accelerate development.
Assess markets, unmet needs, and pricing trends quickly. Validate asset potential using clinical and payer data. Strengthen investor materials with evidence-backed insights — no dedicated market intelligence team required.
Validate Targets and Mechanisms Faster with AI-Powered Research
Smarter Clinical Trials with Higher Probability of Success
Conduct Market Landscape Assessments Without Large Teams
Strengthen Investor and Board Presentations with Defensible Data
Perform Scientific and Commercial Due Diligence at a Fraction of Traditional Costs
Generate protocol-specific literature reviews by trial phase, therapeutic area, and region, automating extraction of comparators, endpoints, biomarkers, and regulatory precedents—with full source traceability for audits and sponsor validation.
Continuously track global regulatory updates, trial guidelines, and HTA shifts while automating data aggregation across sponsor programs to scale operations without increasing headcount.
Reduce manual work for medical writers by automating evidence grids, comparator tables, and summaries—enabling faster, high-value content for protocols and submissions, with full citation trails for audit readiness and compliance.
Benchmark study designs and endpoints using real-time competitive intelligence to enhance strategic value and differentiation during trial design, feasibility, and regulatory planning.
Generate branded reports, dossiers, and analytics tailored to sponsor needs—delivering faster, customized outputs without manual bespoke efforts.
Accelerate Sponsor Project Delivery — Reduce Evidence Synthesis from Weeks to Hours
Scale Across Multiple Sponsors with Automated Pipelines
Reduce Manual Burden for Medical Writers and Scientific Teams
Ensure Regulatory Compliance and Audit Readiness
Increase Sponsor Satisfaction and Win Repeat Business
Monitor global regulations across agencies and device classes, access filterable evidence by indication and region, and anticipate changes affecting trials and market strategies.
Streamline labeling, documentation, and claims review by reusing validated content with full traceability—reducing errors, shortening cycles, and ensuring compliance with local standards.
Automate literature reviews on device performance, safety, and economics to accelerate submissions, payer discussions, and evaluations—backed by auditable, evidence-based claims.
Unify regulatory and commercial teams with shared dashboards combining HTA outcomes, cost benchmarks, and reimbursement insights—aligning dossiers, submissions, and payer strategies with real-world evidence.
Export fully referenced, regulatory-ready reports tailored for MDR/IVDR, FDA, and more—simplifying dossier creation, audits, and multi-market compliance.
Reduce Compliance Risk by Proactively Tracking Global Regulatory Shifts
Streamline Labeling, Claims, and Clinical Documentation Across Markets
Accelerate Evidence Readiness Across Safety, Performance, and Cost-Effectiveness Domains
Enhance Regional Submission Readiness with Audit-Ready, Referenced Outputs
Unify Regulatory and Commercial Teams Around Shared Data and Evidence Models
Instantly access structured cross-therapy intelligence with advanced filters—cutting data collection time to focus on deeper analysis and strategy.
Equip junior teams with validated, traceable insights via pre-built modules—speeding up ramp-up time and ensuring consistent quality at scale.
Expand into new therapies and markets with live HTA data and trends—supporting evidence-backed reimbursement strategies without starting from scratch.
Deliver strategic advice backed by real-time intelligence and scenario modeling—building client confidence with traceable, board-ready insights.
Create proposals, landscapes, and analyses with exportable templates—shortening pitch cycles through AI-powered, consulting-grade client presentations.
Accelerate pitch-to-delivery timelines by minimizing upfront research and synthesis
Equip junior team members with validated insights and plug-and-play modules
Expand into new therapeutic areas with pre-curated, regularly updated data
Differentiate your firm with real-time, AI-driven insights and competitive intelligence
Strengthen client trust through structured, defensible, and traceable recommendations
Win more business with faster, smarter, and deeper proposals backed by evidence
Trusted by global pharma, biotechs, and life sciences leaders
Pienomial exceeded our expectations. Development Strategy Dossier delivers strategic insights across clinical and commercial domains — and we’re excited to expand its use across more teams.
Pienomial has been a trusted partner for over five years. Their intelligent solutions are embedded in our product delivery workflows and remain critical to our operational efficiency.
Knolens has transformed the way we work. Pienomial’s relentless focus on innovation helps us stay ahead in a highly competitive landscape.
With Knolens, what used to take weeks of manual review now takes minutes — and we can trust every result.
